Literature DB >> 19188821

Endocervical adenocarcinoma in situ, serous type.

Sharon Nofech-Mozes, Mahmoud A Khalifa.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19188821     DOI： 10.1097/PGP.0b013e31818e30f6

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN： 0277-1691            Impact factor:   2.762


× No keyword cloud information.
  4 in total

1.  Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.

Authors:  Simona Stolnicu; Iulia Barsan; Lien Hoang; Prusha Patel; Luis Chiriboga; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Malcolm C Pike; Esther Oliva; Kay J Park; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2018-08       Impact factor: 6.394

2.  The association between expression of p53 and aggressiveness of serous adenocarcinoma of the uterine cervix.

Authors:  Sul Lee; Hyun Joo Lee; Kyung Un Choi; Byung Su Kwon; Dong Soo Suh; Dae Hoon Jeong; Geun Joo Kim; Tae Hwa Lee; Hyun-Jin Roh; Ki Hyung Kim
Journal:  J Res Med Sci       Date:  2020-05-22       Impact factor: 1.852

3.  Advanced papillary serous carcinoma of the uterine cervix: a case with a remarkable response to paclitaxel and carboplatin combination chemotherapy.

Authors:  Masashi Ueda; Masafumi Koshiyama; Ayaka Yamaguchi; Shingo Ukita; Masayo Ukita; Kenji Hishikawa; Kazuyo Kakui; Tomoko Kim; Tomoyuki Shirase
Journal:  Rare Tumors       Date:  2011-12-20

4.  Papillary serous carcinoma of the uterine cervix with lung metastasis.

Authors:  Maliha Khan; Alan D Gilman; Sobia Nizami; Aram Barbaryan; Alaa M Ali; Aibek E Mirrakhimov
Journal:  Case Rep Oncol Med       Date:  2014-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.